Moody’s affirms Stormont-Vail HealthCare’s ‘A2’ rating

Moody’s Investors Service has affirmed the “A2” rating assigned to Topeka, Kan.-based Stormont-Vail HealthCare’s fixed rate revenue bonds, affecting $166.3 million.

Advertisement

The rating affirmation is based on several factors, including SVHC’s leading market position in a stable service area, track record of profitability and maintenance of good debt coverage ratios.

The outlook remains stable, reflecting Moody’s expectation that SVHC will continue to benefit from its market position to generate solid operating margins, good debt coverage and improved liquidity ratios.

More hospital outlook and credit rating actions:
Moody’s revises Temple University Health System’s outlook to developing
Moody’s affirms Cullman Regional Medical Center’s ‘Ba1’ rating
Moody’s affirms Longmont United Hospital’s ‘Baa2’ rating

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.